U.S. Antidiabetics Market, 2026-2033

Name: U.S. Antidiabetics Market
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The antidiabetics market in the United States is expected to reach a projected revenue of US$ 89,269.1 million by 2033. A compound annual growth rate of 10.3% is expected of the United States antidiabetics market from 2026 to 2033.

Pharmaceuticals
- Metabolic Disorders Treatment
  - antidiabetics market

U.S. antidiabetics drug class outlook (Revenue, USD million, 2021-2033)
- Insulin
  - Long-acting insulin
  - Premix insulin
  - Fast-acting insulin
  - Human insulin
- GLP-1 Receptor Agonists
- DPP- 4 Inhibitors
- SGLT2 Inhibitors
- Others
U.S. antidiabetics diabetes type outlook (Revenue, USD million, 2021-2033)
- Type 1
- Type 2
U.S. antidiabetics distribution channel outlook (Revenue, USD million, 2021-2033)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
U.S. antidiabetics route of administration outlook (Revenue, USD million, 2021-2033)
- Oral
- Subcutaneous
- Intravenous

U.S. Antidiabetics Market, 2026-2033

Data Tree

Sign up - it's easy, and free!